Janux, Vir stocks rally on positive data for Janux drug JANX007
Shares of Janux (NASDAQ:JANX) shot up 48% in post-market trading Monday after the company reported positive data from a Phase ...
Renal & Urology News22 小时
Radium-223 Prolongs rPFS, OS in mCRPC With Bone Metastases
Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD.